Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Dey Saptaswa |
Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen
Lackner, A; Burner, T; Brandner, M; Aigner, S; Buxhofer-Ausch, V; Geroldinger-Simic, M; Dey, S; Iselin, C; Chang, Y; Tsai, Y; Wolf, P; Kimeswenger, S; Guenova, E; Hötzenecker, W
Immunogenic cell death (ICD) and ICDdependent dendritic cell activation triggered by extracorporeal photopheresis in CTCL
EXP DERMATOL. 2025; 34(3):
Web of Science
Dey, S; Sorger, H; Schlederer, M; Perchthaler, I; Kenner, L; Moriggl, R; Wolf, P
Targeting the hyperactive STAT3/5 Pathway in Cutaneous T-Cell Lymphoma: superior efficacy of multi-kinase inhibitor IQDMA over conventional PUVA therapy
EUR J CANCER. 2024; 211: S14-S15.
Doi: 10.1016/j.ejca.2024.114371
[Poster]
Web of Science
FullText
FullText_MUG
Dey, S; Vieyra-Garcia, PA; Joshi, AA; Trajanoski, S; Wolf, P
Enhanced Phototherapeutic Efficacy Through Microbial Modulation in Cutaneous T-Cell Lymphoma delays tumour growth and increases survival in the murine EL4 model
EUR J CANCER. 2024; 211: S5-S6.
Doi: 10.1016/j.ejca.2024.114349
[Poster]
Web of Science
FullText
FullText_MUG
Lackner, A; Kimeswenger, S; Brandner, M; Aigner, S; Buxhofer-Ausch, V; Geroldinger-Simic, M; Dey, S; Wolf, P; Chang, YT; Tsai, YC; Guenova, E; Hötzenecker, W
Immunogenic Cell Death (ICD) and ICD-dependent Dendritic Cell Activation triggered by Extracorporeal Photopheresis in CTCL
EUR J CANCER. 2024; 211: S6-S7.
Doi: 10.1016/j.ejca.2024.114351
[Poster]
Web of Science
FullText
FullText_MUG
Dey, S; Vieyra-Garcia, P; Joshi, A; Wolf, P
Modulation of the skin microbiome in cutaneous T-cell lymphoma delays tumor growth and increases survival in a murine model
J INVEST DERMATOL. 2023; 143(5):S178-S178.-1st International Societies for Investigative Dermatology Meeting; MAY 12-13, 2023; Tokyo, JAPAN.
[Poster]
Web of Science
Dey, S; Wolf, P
Inhibition of STAT3/5 pathway by multi-kinase inhibitor IQDMA reduces tumor growth and outperforms conventional phototherapeutic treatment regime in cutaneous T cell lymphoma murine model
J INVEST DERMATOL. 2023; 143(11):S373-S373.-5th Inflammatory Skin Disease Summit (ISDS); NOV 15-18, 2023; Vienna, AUSTRIA.
[Poster]
Web of Science
Alonso, IGD; Zujo, L; Krsmanovic, I; Kodojova, P; Schlederer, M; Timelthaler, G; Edtmayer, S; Giordano, C; Kothmayer, M; Neubauer, HA; Dey, S; Pusch, O; Hogler, S; Tangermann, S; Schiefer, A; Kornauth, C; Stoiber, PWD; Staber, P; Klapper, W; Woessmann, W; Gunning, P; Turner, S; Moriggl, R; Lagger, S; Kenner, L
PDGFR beta DRIVES PROGRESSION BY ONCOGENE TRANSCRIPTION THROUGH STAT3/STAT5 HYPERACTIVATION IN ALCL
LEUKEMIA RES. 2022; 121: S69-S69.
Web of Science
Dey, S; Sorger, H; Vieyra-Garcia, P; Teufelberger, A; Herling, M; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
STAT3/5 locus gain is a disease marker and therapeutic target in leukemic/ cutaneous T cell lymphoma
J INVEST DERMATOL. 2022; 142(12): S254-S254.
Web of Science
Dey, S; Sorger, H; Vieyra-Garcia, P; Araujo, ED; Graf, R; Spiegl, B; Schlederer, M; Graier, T; Perchthaler, I; Fink-Puches, R; Cerroni, L; Surbek, M; Pirker, C; Berger, W; Orlova, A; Herling, M; Merkel, O; Neubauer, HA; Gunning, PT; Heitzer, E; Kenner, L; Moriggl, R; Wolf, P
STAT5 is a therapeutically targetable vulnerability in leukemic cutaneous T-cell lymphoma
EXP DERMATOL. 2021; 30(3):E100-E101.
[Poster]
Web of Science
Dey, S; Sorger, H; Vieyra-Garcia, PA; de Araujo, ED; Graf, R; Spiegl, B; Lazzeri, I; Herling, M; Neubauer, HA; Merkel, O; Heitzer, E; Gunning, PT; Kenner, L; Moriggl, R; Wolf, P
Chromosome # 17q (17q11.2-17q21.31) gain is a disease marker and therapeutic vulnerability in Sezary Syndrome
EXP DERMATOL. 2021; 30: 14-14.-4th Inflammatory Skin Disease Summit; NOV 03-06, 2021; New York, NY.
[Poster]
Web of Science
Vieyra-Garcia, PA; Jakic, M; Dey, S; Perchtaler, I; Wolf, P
Cutaneous T cell lymphoma mouse model used to study the therapeutic mechanisms of phototherapy
EUR J CANCER. 2019; 119: S14-S14.-EORTC-CLTF Meeting on Cutaneous Lymphoma - Insights in Research and Catient Care; SEP 26-28, 2019; Athens, GREECE.
[Poster]
Web of Science
Dey, S; Vieyra-Garcia, PA; Kenner, L; Merkel, O; Wolf, P
Inhibition of STAT5 with IQDMA reduces cell viability in cutaneous T cell lymphoma cells in-vitro and decreases tumor growth in a lymphoma animal model
EXP DERMATOL. 2018; 27: 28-29.-3rd Inflammatory Skin Disease Summit; DEC 12-15, 2018; Vienna, AUSTRIA.
[Poster]
Web of Science